Skip to content
akaturk Academic measurement

Article detail · 2021

Is sitagliptin effective for the treatment of COVID-19?

Journal

European Journal of Hospital Pharmacy

ISSN 2047-9956

YÖKSİS OpenAlex Open access · green SJR Q2 JCR Q3 Citations 4 Percentile 56.9% FWCI 0.32
Year
2021
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue European Journal of Hospital Pharmacy
  • Catalog match (ISSN) European Journal of Hospital Pharmacy
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

Cluster of differantiation 26 (CD26) plays an important role in chronic graft versus host disease (GVHD), psoriasis, diabetes, haematological and solid cancers. In addition, S1, the spike protein of Middle East respiratory syndrome coronavirus, has been shown to enter human host cells using CD26, also known as dipeptidyl peptidase-4 (DPP-4), as a functional receptor.1 In a molecular docking study, it was determined that the S1 domain of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein could potentially interact with CD26, an important immunoregulatory factor for hijacking and virulence.2 In a retrospective observational case-control study, 338 patients with type 2 diabetes and coronavirus disease 2019 (COVID-19) were matched 1:1 for age and gender. …

Topics

  • Peptidase Inhibition and Analysis
  • Neuropeptides and Animal Physiology
  • Neuroendocrine Tumor Research Advances

Primary topic Peptidase Inhibition and Analysis

Authors

  1. HASAN MEMİŞ AFYONKARAHİSAR SAĞLIK BİLİMLERİ ÜNİVERSİTESİ
  2. AHMET ÇAKIR
  3. MEFKÜRE DURMUŞ KARADENİZ TEKNİK ÜNİVERSİTESİ
  4. SELİM GÖK
  5. ÖMER FARUK BAHÇECİOĞLU